Connect with us

Health & Science

GcMAF – Threat to the Medical Pharmaceutical Regulatory Complex?

Over the past several weeks no less than seven established doctors have either been killed or died under unusual circumstances.

What do these physicians have in common and what remedies are they researching or advocating? Do any of their proposed treatments pose a threat to the multi-billion dollar pharmaceutical cartel? If so, would government agencies and/or private contractors be commissioned to harass and perhaps even assassinate such individuals?

The answer may lie in an understanding of nagalese, a protein made by cancer cells and viruses. Nagalese is a primary cause of immunodeficiency given its ability to block the body’s production of GcMAF, otherwise known as “Vitamin D binding microphage activating factor,” a naturally-produced immune regulating compound that aids in fighting what are traditionally considered terminal diseases. Some researchers suggest that nagalese is one of many toxic components found in the immunizations commonly administered to children, including the Measles-Mumps-Rubella vaccine.

https://www.youtube.com/watch?v=cALgIHETMDU

Some independently-minded medical practitioners are beginning to acknowledge not only the nagalese-vaccination link, but also that GcMAF possesses great potential for the treatment of cancer and a variety of other illnesses, including autism, inflammation, and viral and bacterial disease.

The most prominent of the seven doctors who’ve been murdered or died under suspicious circumstances is James Jeffrey Bradstreet. As the contents of his blog drbradstreet.org suggest, Dr. Bradstreet has conducted extensive research into the causes of autism. His body was found on June 19 floating in a North Carolina river with a gunshot wound to his chest. Perhaps uncoincidentally, Bradstreet was a strong advocate of GcMAF and had treated over 2,000 autistic children with the substance; 85% exhibited marked improvement under his care.

Dr. Bradstreet’s private practice in Buford, Georgia centered on “treating children with Autism Spectrum Disorder, PPD, and related neurological and developmental disorders.” Bradstreet has also provided expert testimony in federal court for families of the vaccine-injured and was founder and president of the International Child Development Resource Center, which once employed autism expert Dr. Andrew Wakefield as its research director.

Of course, GcMAF is not approved by the Food and Drug Administration as a treatment for any disease. Just three days before Bradstreet’s body was recovered, FDA agents had obtained a court order targeting Bradstreet’s Buford Georgia medical clinic. The document granted the government the right to seize

All Globulin component Macrophage Activating Factor (GcMAF) GC Globulin, and/or any other products or component substances thereof that constitute misbranded drugs under the Federal Food, Drugs and Cosmetic Act.

Even in death Bradsteet and his GcMAF-related work continue to pose a threat to the medical-pharmaceutical-regulatory complex, as evidenced in their flak-generating public relations arms, “Quackwatch” and “Science Based Medicine,” each of which have published vicious broadsides on the deceased physician.

Big pharma, which for decades has exerted vigorous control over the regulatory process while presiding over literally millions of deaths via its products, will stop at nothing to hamper medical scientific progress and protect its bottom line. Perhaps this zealous quest for profits and control now even includes outright murder of alternative practitioners.

 

daily alternative | alternative news – GcMAF – Threat to the Medical Pharmaceutical Regulatory Complex?

via GcMAF – Threats to the Medical Pharmaceutical Regulatory Complex? Doctors have Died under Suspicious Circumstances

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Health & Science

Google Now Has Access To Millions of Patients’ Medical Records

A controversial deal between tech giant Google and the National Health Service (NHS) will allow artificial intelligence units access to 1.6 million confidential medical records. Since 2014, Google has partnered with several scientists in an attempt to understand human health, but a new report reveals the data gathering goes far beyond what was originally anticipated.

According to documents obtained by the New Scientist, the data sharing agreement between Google-owned artificial intelligence company DeepMind and the Royal Free NHS Trust gives access to the sensitive healthcare data of millions of NHS patients. The chilling and wide-reaching deal allows DeepMind access to the medical records of the 1.6 million people passing annually through the three London hospitals owned by the Trust — Barnet, Chase Farm, and the Royal Free.

The Google-owned A.I. firm announced in February it was working with the NHS to build an app called Streams — intended to help hospitals monitor patients with kidney disease. However, the new information has revealed that the extent of the data being shared goes much further and includes logs of day-to-day hospital activity, records of the location and status of patients, and even logs of who visits them and when.

Results of pathology and radiology tests are also shared, as is information from critical care and accident and emergency departments. In addition, DeepMind’s access to the centralised records of all NHS hospital treatments in the U.K. means the tech company can access historical data from the last five years, all while receiving a continuous stream of new data.

At the same time, DeepMind is developing a platform called Patient Rescue, which uses hospital data streams to build tools to carry out analysis and support diagnostic decisions. The New Scientist explained how it works:

Comparing a new patient’s information with millions of other cases, Patient Rescue might be able to predict that they are in the early stages of a disease that has not yet become symptomatic, for example. Doctors could then run tests to see if the prediction is correct.

While the Royal Free has not yet responded to the question of what — if any — opt-out mechanisms are available to patients, the New Scientist suggests this is unlikely to be a straightforward process. Despite the agreement stating Google cannot use the data in any other part of the company’s business, many will be seriously wary of the access the online tech giant now has to the confidential data of millions of people.

As the New Scientist wrote:

Data mining is the name of the game in the burgeoning field of machine learning and artificial intelligence, and there’s no company in the world better at that than Google.

 

daily alternative | alternative news – Google Now Has Access To Millions of Patients’ Medical Records

via Google Now Has Access To Millions of Patients’ Medical Records.

Continue Reading
  • Latest Crypto Price

    1 BTC = $11878.31 USD  (via Coinbase)
    1 ETH = $435.57 USD  (via Coinbase)
    Quotes delayed up to 3 minutes.

    Follow us on Twitter

    Facebook

    Trending

    By continuing to use the site, you agree to the use of cookies. more information

    The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

    Close